Lazard Asset Management
CRL icon

Lazard Asset Management’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.09M Buy
7,198
+2,952
+70% +$448K ﹤0.01% 1274
2025
Q1
$639K Sell
4,246
-6,511
-61% -$980K ﹤0.01% 1344
2024
Q4
$1.99M Buy
10,757
+3,194
+42% +$589K ﹤0.01% 883
2024
Q3
$1.49M Sell
7,563
-27,487
-78% -$5.41M ﹤0.01% 951
2024
Q2
$7.24M Sell
35,050
-30,184
-46% -$6.23M 0.01% 588
2024
Q1
$17.7M Buy
65,234
+10,928
+20% +$2.96M 0.02% 411
2023
Q4
$12.8M Buy
54,306
+2,269
+4% +$536K 0.02% 497
2023
Q3
$10.2M Buy
52,037
+33,918
+187% +$6.65M 0.01% 557
2023
Q2
$3.81M Buy
18,119
+2,855
+19% +$600K ﹤0.01% 763
2023
Q1
$3.08M Buy
15,264
+500
+3% +$101K ﹤0.01% 828
2022
Q4
$3.22M Buy
14,764
+722
+5% +$157K ﹤0.01% 808
2022
Q3
$2.76M Buy
14,042
+3,991
+40% +$785K ﹤0.01% 818
2022
Q2
$2.15M Buy
10,051
+10,047
+251,175% +$2.15M ﹤0.01% 889
2022
Q1
$1K Buy
4
+2
+100% +$500 ﹤0.01% 2277
2021
Q4
$0 Sell
2
-27,425
-100% ﹤0.01% 2311
2021
Q3
$11.3M Sell
27,427
-100,626
-79% -$41.5M 0.01% 599
2021
Q2
$47.4M Sell
128,053
-3,262
-2% -$1.21M 0.05% 290
2021
Q1
$38.1M Sell
131,315
-25,313
-16% -$7.34M 0.05% 315
2020
Q4
$39.1M Sell
156,628
-10,757
-6% -$2.69M 0.05% 307
2020
Q3
$37.9M Sell
167,385
-39,585
-19% -$8.96M 0.05% 269
2020
Q2
$36.1M Buy
206,970
+20,947
+11% +$3.65M 0.06% 237
2020
Q1
$23.5M Buy
186,023
+5,694
+3% +$719K 0.04% 278
2019
Q4
$27.5M Buy
180,329
+44,303
+33% +$6.77M 0.04% 294
2019
Q3
$18M Buy
136,026
+90,419
+198% +$12M 0.03% 366
2019
Q2
$6.47M Buy
45,607
+1,500
+3% +$213K 0.01% 541
2019
Q1
$6.41M Buy
44,107
+40,157
+1,017% +$5.83M 0.01% 543
2018
Q4
$447K Buy
3,950
+2,646
+203% +$299K ﹤0.01% 806
2018
Q3
$175K Buy
+1,304
New +$175K ﹤0.01% 884
2016
Q1
Sell
-2,750
Closed -$221K 1055
2015
Q4
$221K Buy
2,750
+400
+17% +$32.1K ﹤0.01% 808
2015
Q3
$149K Sell
2,350
-655
-22% -$41.5K ﹤0.01% 816
2015
Q2
$211K Buy
+3,005
New +$211K ﹤0.01% 831